CNTMF (FLUENT) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is FLUENT ROE % Adjusted to Book Value?

FLUENT's ROE % for the quarter that ended in Sep. 2024 was 0.00%. FLUENT's PB Ratio for the quarter that ended in Sep. 2024 was N/A. FLUENT's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was N/A.

FLUENT ROE % Adjusted to Book Value Historical Data

The historical data trend for FLUENT's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FLUENT ROE % Adjusted to Book Value Chart

FLUENT Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-62.53

-18.74

-15.37

-76.90

-41.00

FLUENT Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-69.98	-50.56	-18.22	10.83	-

Competitive Comparison of FLUENT's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, FLUENT's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FLUENT's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, FLUENT's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where FLUENT's ROE % Adjusted to Book Value falls into.

FLUENT ROE % Adjusted to Book Value Calculation

FLUENT's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-125.88%	/	3.07
	=	-41.00%

FLUENT's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

FLUENT ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of FLUENT's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

FLUENT Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FLUENT Corp (OTCPK:CNTMF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

2WM0:Germany FNT.U:Canada

Address

82 North East 26th Street, Unit 110, Miami, FL, USA, 33137

Website

https://getfluent.com

Cansortium Inc is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flowers, pre-rolls, cartridges, and edibles. All of the company's products are marketed under the Fluent brand name. In Pennsylvania, the company's product portfolio is comprised of a variety of third-party branded medical cannabis products.